Bimzelx 320 MG/2 ML autoinject 2ML
Ended Awarded
- Contract number
- SPE2DR26F8YDV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,386
Award facts
- Contract value 100% obligated
- $12,385.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $12,385.86 delivery order to AmerisourceBergen Drug Corp for BIMZELX 320 MG/2 ML auto-injector units on October 20, 2025, with an ultimate completion date of October 21, 2025. This is a firm fixed-price, non-set-aside contract for delivery to the company's facility in Conshohocken, Pennsylvania. BIMZELX (bimekizumab) is a biologic immunosuppressant used to treat inflammatory skin conditions, and this delivery order represents a focused pharmaceutical procurement within the broader Defense Logistics Agency medical supply chain.
This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen Drug Corp supplies an extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies to support military healthcare programs and other government healthcare systems. The parent IDC vehicle enables the company to fulfill individual delivery orders across multiple therapeutic domains, supporting the Defense Health Agency, U.S. Coast Guard, and other federal customers worldwide on a competitive basis.
Quick answers
Who was awarded contract SPE2DR26F8YDV?
SPE2DR26F8YDV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 20, 2025.
How much is contract SPE2DR26F8YDV worth?
The government has obligated $12,386 on SPE2DR26F8YDV.
Is contract SPE2DR26F8YDV an order under another contract?
Yes. SPE2DR26F8YDV is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F8YDV competed?
The extent of competition for SPE2DR26F8YDV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award